Purdue Pharma Pleads Guilty to DOJ Criminal Charges in Opioid Case

The pharmaceutical company has pled guilty to federal criminal charges and agrees to pay $8.3 billion in penalties.

Purdue Pharma has settled with the U.S. Department of Justice (DOJ) on criminal charges from its role in the opioid epidemic. State and local lawsuits against the company remain in play.

The Washington Post reports:

Purdue Pharma agreed to plead guilty in federal court in New Jersey to three felony counts for defrauding the United States and violating the anti-kickback statute from 2009 to 2017 in what the Justice Department said was “the largest penalties ever levied against a pharmaceutical manufacturer.” The $8.3 billion global settlement includes a criminal fine of $3.544 billion, criminal forfeiture of $2 billion and a civil settlement of $2.8 billion.

From The New York Times:

The company’s owners, members of the wealthy Sackler family, will pay $225 million in civil penalties. Federal prosecutors said the settlement did not preclude criminal charges against Purdue executives or individual Sacklers.

Wednesday’s announcement does not conclude the extensive litigation against Purdue, but it does represent a significant advance in the long legal march by states, cities and counties to compel the most prominent defendant in the opioid epidemic to help pay for the public health crisis that has resulted in the deaths of more than 450,000 Americans since 1999, according to the Centers for Disease Control and Prevention.

For more information:

Purdue Pharma agrees to plead guilty to federal criminal charges in settlement over opioid crisis (The Washington Post)

Purdue Pharma Pleads Guilty to Criminal Charges for Opioid Sales (New York Times)